Title: Guidelines for using NMDP slides
1Guidelines for using NMDP slides
- The information and data in this presentation
were prepared by the National Marrow Donor
Program (NMDP). Each slide and/or information may
be used in its entirety in presentations and
publications as long as it is attributed to the
National Marrow Donor Program. - When used in presentations, NMDP slides should
retain their content, appearance and design. (For
instructions on copying the design along with the
contents, see the notes to this slide.) - Presentation notes are included to supplement the
slide content. To print the notes, select Notes
Pages in your printer window. - To download the file to your computer, select
Save As in the File menu.
2Acute Myelogenous LeukemiaSurvival of Adult (Age
³ 18 Years) Marrow Recipients with Myeloablative
Preparative Regimens, by Disease Stage 19982006
Log-rank p-value lt 0.0001
Second complete remission (n 264)
First complete remission (n 274)
Advanced (n 479)
3Acute Myelogenous LeukemiaSurvival of Adult (Age
³ 18 Years) PBSC Recipients with Myeloablative
Preparative Regimens, by Disease Stage 19982006
Log-rank p-value lt 0.0001
First complete remission (n 352)
Second complete remission (n 200)
Advanced (n 363)
4Acute Myelogenous LeukemiaSurvival of Pediatric
(Age lt 18 Years) Marrow Recipients with
Myeloablative Preparative Regimens, by Disease
Stage 19982006
Log-rank p-value 0.0004
Second complete remission (n 137)
First complete remission (n 98)
Advanced (n 116)
5Acute Myelogenous LeukemiaSurvival of Older
Adult (Age ³ 55 Years) Marrow and PBSC Recipients
with Non-Myeloablative Preparative Regimens, by
Disease Stage 19982006
Log-rank p-value 0.0002
Second complete remission (n 107)
First complete remission (n 239)
Advanced (n 113)
6Acute Myelogenous LeukemiaSurvival of Older
Adult (Age ³ 55 Years) Marrow and PBSC Recipients
with Myeloablative Preparative Regimens, by
Disease Stage 19982006
Log-rank p-value 0.009
First complete remission (n 82)
Second complete remission (n 44)
Advanced (n 69)